€500,000 to industrialize our pharmaceutical inks and equip the first pilot pharmacies by 2026. Discover how this strategic support will accelerate our deployment.
Meet our Chief Business Officer, appointed to accelerate our commercial development and expand our model internationally.
Discover the journey of Morenikeji Aina, joining MB Therapeutics to help accelerate innovation in pharmaceutical formulation.
MB Therapeutics is one of the startups highlighted at SantExpo 2025 alongside the University of Montpellier’s Innovation Hub (PUI).
MB Therapeutics redesigns its offices with Les Simones, combining sustainable design, second-hand furniture, and a strong local CSR commitment.
MB Therapeutics welcomes its responsible pharmacist and CQO to strengthen its production of GMP-certified pharmaceutical inks.
MB Therapeutics has settled into its new premises. New address, same tight-knit team, and even more energy!
From Rotterdam to Lyon… The MB Therapeutics team took part in key events where pharmaceutical innovation was at the heart of the discussions.
MB Therapeutics raises €2 million to industrialize and launch a solution for the manufacturing of personalized medicines in pharmacies.
A year ago, MB Therapeutics began its journey with a clear mission: to provide innovative solutions in the field of healthcare.